BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Gastric cancer AND BUB1B, BUBR1, 701, ENSG00000156970, SSK1, BUB1beta, MAD3L, hBUBR1, Bub1A, O60566 AND Prognosis
21 results:

  • 1. Total Versus Subtotal Gastrectomy for Distal gastric Poorly Cohesive Carcinoma.
    Boubaddi M; Teixeira Farinha H; Lambert C; Pereira B; Piessen G; Gualtierotti M; Voron T; Mantziari S; Pezet D; Gronnier C;
    Ann Surg Oncol; 2024 Feb; 31(2):744-752. PubMed ID: 37971616
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. The diagnostic value of serum insulin-like growth factor binding protein 7 in gastric cancer.
    Liu CT; Wu FC; Zhuang YX; Huang XY; Li XH; Qu QQ; Peng YH; Xu YW; Chen SL; Huang XC
    PeerJ; 2023; 11():e15419. PubMed ID: 37304887
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Constructing a novel mitochondrial-related gene signature for evaluating the tumor immune microenvironment and predicting survival in stomach adenocarcinoma.
    Chang J; Wu H; Wu J; Liu M; Zhang W; Hu Y; Zhang X; Xu J; Li L; Yu P; Zhu J
    J Transl Med; 2023 Mar; 21(1):191. PubMed ID: 36915111
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Tertiary lymphoid structures and gastric cancer prognosis.
    Kemi N; Ylitalo O; Väyrynen JP; Helminen O; Junttila A; Mrena J; Böhm J; Kauppila JH
    APMIS; 2023 Jan; 131(1):19-25. PubMed ID: 36205614
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Circulating exosomal gastric cancer-associated long noncoding RNA1 as a noninvasive biomarker for predicting chemotherapy response and prognosis of advanced gastric cancer: A multi-cohort, multi-phase study.
    Song Q; Lv X; Ru Y; Dong J; Chang R; Wu D; Chen L; Wang X; Guo X
    EBioMedicine; 2022 Apr; 78():103971. PubMed ID: 35349826
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Clinical significance of lower perigastric lymph nodes dissection in Siewert type II/III adenocarcinoma of esophagogastric junction: a retrospective propensity score matched study.
    Li ZL; Zhao LY; Zhang WH; Liu K; Pang HY; Chen XL; Chen XZ; Yang K; Hu JK
    Langenbecks Arch Surg; 2022 May; 407(3):985-998. PubMed ID: 34792614
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Expression and prognosis analyses of BUB1, bub1b and BUB3 in human sarcoma.
    Long Z; Wu T; Tian Q; Carlson LA; Wang W; Wu G
    Aging (Albany NY); 2021 Apr; 13(9):12395-12409. PubMed ID: 33872216
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. [Neoadjuvant chemoradiotherapy combined with surgery versus direct surgery in the treatment of Siewert type II and III adenocarcinomas of the esophagogastric junction: long-term prognostic analysis of a prospective randomized controlled trial].
    Tian Y; Wang Q; Wang J; Qiao XY; Zhang J; Lin YC; Li Y; Fan LQ; Yang PG; Zhao Q
    Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Feb; 24(2):128-137. PubMed ID: 33508918
    [No Abstract]    [Full Text] [Related]  

  • 9. Identifying of biomarkers associated with gastric cancer based on 11 topological analysis methods of CytoHubba.
    Ma H; He Z; Chen J; Zhang X; Song P
    Sci Rep; 2021 Jan; 11(1):1331. PubMed ID: 33446695
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. gastric Adenocarcinoma in a Moroccan Population: First Report on Survival Data.
    Lahmidani N; Miry S; Abid H; El Yousfi M; Benajah D; Ibrahimi A; El Abkari M; Najdi A
    Gulf J Oncolog; 2019 Sep; 1(31):36-40. PubMed ID: 31591989
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Nomograms for predicting survival in patients with metastatic gastric adenocarcinoma who undergo palliative gastrectomy.
    Ma T; Wu ZJ; Xu H; Wu CH; Xu J; Peng WR; Fan LL; Sun GP
    BMC Cancer; 2019 Aug; 19(1):852. PubMed ID: 31462229
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Effects of metastasectomy and other factors on survival of patients with ovarian metastases from gastric cancer: a systematic review and meta-analysis.
    Zhang C; Hou W; Huang J; Yin S; Wang P; Zhang Z; Tan Y; Xu H
    J Cell Biochem; 2019 Sep; 120(9):14486-14498. PubMed ID: 31050365
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Comparable rates of lymph node metastasis and survival between diffuse type and intestinal type early gastric cancer patients: a large population-based study.
    Li ZY; Zhang QW; Teng LM; Zhang CH; Huang Y
    Gastrointest Endosc; 2019 Jul; 90(1):84-95.e10. PubMed ID: 30885598
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Predictive Value of Two Polymorphisms of ERCC2, rs13181 and rs1799793, in Clinical Outcomes of Chemotherapy in gastric cancer Patients: A Meta-Analysis.
    Li M; Zhao Y; Zhao E; Wang K; Lu W; Yuan L
    Dis Markers; 2018; 2018():3947626. PubMed ID: 30581498
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. The prognostic role of Helicobacter pylori in gastric cancer patients: A meta-analysis.
    Li G; Yu S; Xu J; Zhang X; Ye J; Wang Z; He Y
    Clin Res Hepatol Gastroenterol; 2019 Apr; 43(2):216-224. PubMed ID: 30361060
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Effects of Community Screening for Helicobacter pylori: 13-Year Follow-Up Evaluation of a Randomized Controlled Trial.
    Bomme M; Hansen JM; Wildner-Christensen M; Hallas J; Schaffalitzky de Muckadell OB
    Clin Gastroenterol Hepatol; 2017 Nov; 15(11):1715-1723.e7. PubMed ID: 28606845
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Complete mesocolic excision an assessment of feasibility and outcome.
    Bertelsen CA
    Dan Med J; 2017 Feb; 64(2):. PubMed ID: 28157065
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Extent of Serosal Changes Predicts Peritoneal Recurrence and Poor prognosis After Curative Surgery for gastric cancer.
    Kang Y; Li S; Ge Q; Liu X; Yang Z; Xue Y; Wang F
    Medicine (Baltimore); 2015 Oct; 94(42):e1750. PubMed ID: 26496292
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Abnormal β-catenin immunohistochemical expression as a prognostic factor in gastric cancer: a meta-analysis.
    Li LF; Wei ZJ; Sun H; Jiang B
    World J Gastroenterol; 2014 Sep; 20(34):12313-21. PubMed ID: 25232267
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. High expression of bubr1 is one of the factors for inducing DNA aneuploidy and progression in gastric cancer.
    Ando K; Kakeji Y; Kitao H; Iimori M; Zhao Y; Yoshida R; Oki E; Yoshinaga K; Matumoto T; Morita M; Sakaguchi Y; Maehara Y
    Cancer Sci; 2010 Mar; 101(3):639-45. PubMed ID: 20132214
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 2.